Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDCL3 pseudogene 5 (PDCL3P5) is a human pseudogene related to the phosducin-like protein family, specifically derived from the parent gene PDCL3. Pseudogenes are DNA sequences that resemble known genes but are typically non-functional due to mutations blocking their translation or transcription, although some may have regulatory functions. There is no evidence that PDCL3P5 encodes a protein, is expressed, or has any established functional or disease relevance. By convention, pseudogenes like PDCL3P5 are not considered therapeutic targets, biomarkers, or subjects of pharmacological interest unless future research establishes a relevant role[2][5]. If you meant the parental gene PDCL3, it encodes a chaperone protein involved in G protein signaling, the regulation of VEGFR2, and cellular protein folding, and has established biomarker and oncogene roles[1][3]. However, PDCL3P5 is a distinct, likely non-functional pseudogene with no documented aliases, biological activities, or therapeutic relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDCL3 pseudogene 5 (PDCL3P5).